Intelgenx montelukast clinical trial

Larrytherunner

I posted a few weeks earlier that Intelgenx Technologies in Canada has completed its clinical trial using its film version of montelukast to treat early Alzheimer's and MCI. A brief preliminary report indicated that participants taking the highest dosage of 30 mg twice a day have shown cognitive improvement. A final report should be completed during this quarter (July, August or September).

Intelgenx is now in the process of being taken over by Atai Life Sciences NV. One of Atai's biggest investor is the multi-billion dollar venture capitalist Peter Thiel, the PayPal cofounder, who has also invested millions in anti-aging research.

I starting posting here 8 years ago in 2016 after reading about Dr Ludwig Aigner's research on montelukast's anti-inflammatory effects on neuroinflammation. I started taking montelukast multiple times a day then and the extreme mental fatigue that I was experiencing completely went away after a week. My mother passed away from Alzheimer's and I believe montelukast has prevented me from going down that same path, although I can't prove it and I know most people find it hard to believe.

The article posted below is from Alzheimer's News Today. It is a really great free weekly online newsletter that specializes in research and clinical trials. The articles are written by authors with advanced degrees in the biological sciences. It's a great newsletter to subscribe to if you want to see the latest in Alzheimer's research and clinical trials written in plain English.

https://alzheimersnewstoday.com/news/montelukast-oral-film-aids-cognition-mild-moderate-alzheimers/

White Crane

Larry, thank you for posting this. I've taken Montelukast for years for my asthma. I find it fascinating that it may help with Alzheimer's and MCI.

Iris L.

This is interesting and encouraging. Thanks for posting, Larry.

Iris